Suppr超能文献

一个中国家庭中莱施-奈恩综合征HPRT突变的基因分析。

Genetic analysis of the HPRT mutation of Lesch-Nyhan syndrome in a Chinese family.

作者信息

Lee W J, Lee H M, Chi C S, Yang M T, Lin H Y, Lin W H

机构信息

Division of Endocrinology and Metabolism, Taichung Veterans General Hospital, Taiwan.

出版信息

Zhonghua Yi Xue Za Zhi (Taipei). 1995 Dec;56(6):359-66.

PMID:8851475
Abstract

BACKGROUND

The Lesch-Nyhan syndrome is an X-linked recessive inherited disease caused by a complete deficiency of hypoxanthine guanine phosphoribosyl-transferase (HPRT) activity. Many different mutations throughout the HPRT coding region of Lesch-Nyhan patients have been described, including single base substitutions, partial or entire gene deletions, gene insertions or endoduplication of exons. However, study of gene mutation in Chinese patients has rarely been reported in Taiwan.

METHODS

Polymerase chain reaction (PCR) and nucleotide sequence analysis were used to identify the location and the nature of the mutation at the HPRT locus in two brothers affected with Lesch-Nyhan syndrome. The HPRT cDNA, amplified from total RNA of patient's peripheral blood by reverse transcription-polymerase chain reaction, was cloned into a pGEM-3Zf(-) vector and then sequenced. Family study involved initial screening using single-strand conformation polymorphism, and further confirmation by direct sequencing of the exon encompassing the mutation.

RESULTS

The mutation identified in these two affected siblings was a single nucleotide substitution, from cytosine to guanine, in exon 3 of the HPRT coding region. This transversion putatively caused a single amino acid substitution from phenylalanine to leucine at codon 74 in the translated protein. This base change was further confirmed by direct sequencing of both the HPRT cDNA fragment and the exon 3 of HPRT gene amplified from genomic DNA. The family study revealed that the patient's mother was a heterozygous carrier, and the mutation seemed to have occurred de novo in a germinal cell from one of the maternal grandparents.

CONCLUSIONS

This is the first family study on Chinese patients with Lesch-Nyhan syndrome identified by molecular analysis in Taiwan. The mutation described herein is a novel substitution which occurs in a suggested "hotspot" of mutation (exon 3) of the HPRT gene. The application of molecular analysis of HPRT-gene allows not only DNA diagnosis by directly detecting the mutant alleles, but also prenatal diagnosis and carrier identification within individual families affected by Lesch-Nyhan syndrome.

摘要

背景

莱施-奈恩综合征是一种X连锁隐性遗传病,由次黄嘌呤鸟嘌呤磷酸核糖转移酶(HPRT)活性完全缺乏引起。已描述了莱施-奈恩患者HPRT编码区的许多不同突变,包括单碱基替换、部分或整个基因缺失、基因插入或外显子的内复制。然而,台湾地区关于中国患者基因突变的研究报道很少。

方法

采用聚合酶链反应(PCR)和核苷酸序列分析来确定两名患有莱施-奈恩综合征的兄弟中HPRT基因座突变的位置和性质。通过逆转录-聚合酶链反应从患者外周血总RNA中扩增出HPRT cDNA,将其克隆到pGEM-3Zf(-)载体中,然后进行测序。家系研究包括使用单链构象多态性进行初步筛选,并通过对包含突变的外显子进行直接测序进一步确认。

结果

在这两名受影响的兄弟姐妹中鉴定出的突变是HPRT编码区第3外显子中的单核苷酸替换,从胞嘧啶替换为鸟嘌呤。这种颠换推测导致翻译后的蛋白质在第74密码子处从苯丙氨酸单氨基酸替换为亮氨酸。通过对HPRT cDNA片段和从基因组DNA扩增的HPRT基因第3外显子进行直接测序,进一步证实了这种碱基变化。家系研究表明,患者的母亲是杂合子携带者,该突变似乎是在来自一位外祖母或外祖父的生殖细胞中发生的新生突变。

结论

这是台湾地区通过分子分析鉴定的首例中国莱施-奈恩综合征患者家系研究。本文所述的突变是一种新的替换,发生在HPRT基因的一个推测的突变“热点”(第3外显子)中。HPRT基因的分子分析应用不仅可以通过直接检测突变等位基因进行DNA诊断,还可以在受莱施-奈恩综合征影响的个体家庭中进行产前诊断和携带者鉴定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验